Form 8-K - Current report:
SEC Accession No. 0001144204-13-067110
Filing Date
2013-12-13
Accepted
2013-12-13 12:07:10
Documents
9
Period of Report
2013-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v362850_8k.htm 8-K 25982
2 EXHIBIT 1.1 v362850_ex1-1.htm EX-1.1 262659
3 EXHIBIT 1.2 v362850_ex1-2.htm EX-1.2 14200
4 EXHIBIT 5.1 v362850_ex5-1.htm EX-5.1 16739
5 EXHIBIT 99.1 v362850_ex99-1.htm EX-99.1 8864
6 EXHIBIT 99.2 v362850_ex99-2.htm EX-99.2 10053
7 GRAPHIC image_004.jpg GRAPHIC 6769
8 GRAPHIC logo_001.jpg GRAPHIC 2958
9 GRAPHIC tlogo.jpg GRAPHIC 14296
  Complete submission text file 0001144204-13-067110.txt   373489
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 131275536
SIC: 2834 Pharmaceutical Preparations